SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-004371
Filing Date
2021-09-13
Accepted
2021-09-13 20:08:11
Documents
1
Period of Report
2021-09-09

Document Format Files

Seq Description Document Type Size
1 form4-09132021_050904.html 4  
1 form4-09132021_050904.xml 4 4204
  Complete submission text file 0001415889-21-004371.txt   5665
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 52 SUNRISE PARK ROAD NEW HAMPTON NY 43017
Business Address
Coelho Mary Theresa (Reporting) CIK: 0001720772 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 211250951